Managing chronic disease with individualized metabolomics & artificial intelligence

Christopher Gerner from the Joint Metabolome Facility at the University of Vienna, Austria, walks us through what we need to know about managing chronic disease by individualized metabolomics & artificial intelligence. Gerner discusses both the promise and challenge of developing such biomedical methods, a new methodology termed Metabo-tip, and what the future holds for managing chronic disease. Many acute life-threatening conditions, such as severe injury or bacterial infections, have remained well under control for almost a century. However, chronic diseases such as type 2 diabetes, inflammatory bowel diseases, endometriosis, chronic fatigue syndrome, etc. and the increasing numbers of patients suffering from them still pose a major challenge.